The authors propose a complex scheme in the treatment of a febrile variant of delirium tremens. The main emphasis is made on the use of hemodez possessing an antitoxic property and normalizing metabolism. The use of the mentioned preparation along with neuroleptics and symptomatical therapy as was tried in 30 patients with delirium tremens, permitted to arrest acute disorders, the hyperthermic syndrome and normalize the vital functions of the organism. These measures excluded unfavourable lethal outcomes even in cases complicated by Gayet-Wernicke encephalopathy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treatment febrile
8
febrile variant
8
variant delirium
8
delirium tremens
8
[assessment effectiveness
4
effectiveness hemodes
4
hemodes treatment
4
delirium tremens]
4
tremens] authors
4
authors propose
4

Similar Publications

alleviate Serovar Typhimurium-induced murine inflammatory/oxidative responses via the p62-Keap1-Nrf2 signaling pathway and cecal microbiota.

Front Microbiol

January 2025

Tianjin Key Laboratory of Conservation and Utilization of Animal Diversity, College of Life Sciences, Tianjin Normal University, Tianjin, China.

Background: Serovar Typhimurium (. Typhimurium) infection can cause inflammation and oxidative stress in the body, leading to gastroenteritis, fever and other diseases in humans and animals. More and more studies have emphasized the broad prospects of probiotics in improving inflammation and oxidative stress, but the ability and mechanism of (LA) to alleviate the inflammatory/oxidative reaction caused by pathogens are still unclear.

View Article and Find Full Text PDF

Objective: Immune checkpoint inhibitors (ICI) that block the programmed cell death 1 (PD-1) pathway have shown promise with limited benefit. We and others have shown in small patient cohorts that an early proliferative CD8 T-cell response in the blood may be predictive of clinical response. However, these studies lack detailed analyses and comparisons between monotherapy and combination therapies.

View Article and Find Full Text PDF

Introduction: The aim of the study was to study the clinical profile and outcomes of nocardiosis in renal allograft recipients.

Methods: This was a retrospective study of clinical outcomes in consecutive renal allograft recipients with infection over a 22-year period (2000-2022) from a tertiary care center in Southern India. The clinical data were obtained from electronic medical records and patient files.

View Article and Find Full Text PDF

Introduction: Antibiotic stewardship is a critical aspect of managing cancer patients with febrile neutropenia (FN) to limit the development of drug-resistant organisms and minimize adverse drug effects. Thus, it has been recommended that patients with FN receiving empiric antibiotics should be re-evaluated for safe antibiotic de-escalation.

Methods: Subjects treated with meropenem for febrile neutropenia who met Loyola University Medical Center's (LUMC) criteria for de-escalation were stratified based on whether meropenem was de-escalated, and 30-day all-cause mortality for both groups was assessed.

View Article and Find Full Text PDF

Preparation and evaluation of T4SS recombinant proteins in serodiagnosis of human brucellosis based on TMT-based proteomics technology.

Front Cell Infect Microbiol

January 2025

Jiangsu Engineering Research Center of Biological Data Mining and Healthcare Transformation, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Introduction: Brucellosis, a significant zoonotic infectious disease, poses a global health threat. Accurate and efficient diagnosis is crucial for prevention, control, and treatment of brucellosis. VirB proteins, components of the Type IV secretion system (T4SS) in , play a pivotal role in bacterial virulence and pathogenesis but have been understudied for their diagnostic potential.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!